1-6 of 6
F. Maloisel
Close
Sort by
Journal Articles

Outcome of Acute Promyelocytic Leukemia (APL) with Very High WBC Counts Treated with ATRA and Chemotherapy (CT): The European Group Experience.

C. Kelaidi, S. Chevret, S. de Botton, E. Raffoux, A. Guerci, X. Thomas, C. Gardin, A. Pigneux, A. Stoppa, T. Lamy, F. Rigal-Huguet, A. Vekhoff, S. Meyer-Monard, R. Chelo, T. Pabst, P. Chevalier, F. Maloisel, E. Deconinck, A. Ferrant, D. Bron, N. Fegueux, J. de la Serna, G. Martin, J. Cahn, N. Ifrah, B. Cassinat, H. Dombret, M.A. Sanz, Pierre Fenaux, L. Ades
Journal: Blood
Blood (2007) 110 (11): 1845.
https://doi.org/10.1182/blood.V110.11.1845.1845
Published: 2007
Journal Articles

Variant Philadelphia-Positive Chronic Myeloid Leukemia, der(9) Deletions and Response to Imatinib Mesylate: A Retrospective Multicentric Analysis from the French Fi-LMC Group.

S. Corm, MD, Franck Nicolini, S. Richebourg, F. Huguet, D. Rea, I. Tigaud, N. Dastugue, S. Raynaud, L. Legros, J. van den Akker, F.X. Mahon, F. Maloisel, C. Roche-Lestienne, A. Guerci, C. Preudhomme, V. Eclache
Journal: Blood
Blood (2006) 108 (11): 2113.
https://doi.org/10.1182/blood.V108.11.2113.2113
Published: 2006
Journal Articles

A Multicenter Prospective Randomized Study Testing Non-Inferiority of Thalidomide 100 mg/day as Compared with 400 mg/day in Patients with Refractory/Relapsed Multiple Myeloma: First Results of the Final Analysis of the IFM 01-02 Study.

Ibrahim Yakoub-Agha, C. Hulin, C. Doyen, L. Benboubker, L. Voillat, K. Bouabdallah, G. Guillerm, P. Moreau, F. Maloisel, A.M. Stoppa, B. Pegourie, P. Rodon, M. Dib, P. Casassus, B. Slama, E. Voog, H. Jardel, P. Collet, M. Wettervald, A.M. Peny, P. Mineur, C. Duguet, R. Zerbib, T. Facon, J.Y. Mary
Journal: Blood
Blood (2005) 106 (11): 364.
https://doi.org/10.1182/blood.V106.11.364.364
Published: 2005
Journal Articles

Is ARAC Required in the Treatment of Newly Diagnosed APL? Results of a Randomized Trial (APL 2000).

L. Ades, E. Raffoux, S. Chevret, S. de Botton, A. Guerci, A. Pigneux, A.M. Stoppa, T. Lamy, F. Rigal-Huguet, A. Vekhoff, T. Pabst, S. Meyer-Monard, F. Maloisel, E. Deconinck, D. Caillot, N. Gratecos, J.J. Sotto, A. Ferrant, P. Turlure, X. Thomas, N. Fegueux, P. Brault, O. Reman, P. Chevallier, P. Travade, V. Leblond, G. Leverger, A. Stamatoullas, C. Pautas, B. Beve, C. Chomienne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2004) 104 (11): 391.
https://doi.org/10.1182/blood.V104.11.391.391
Published: 2004
Journal Articles

Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study

E Solary, B Witz, D Caillot, P Moreau, B Desablens, JY Cahn, A Sadoun, B Pignon, C Berthou, F Maloisel, D Guyotat, P Casassus, N Ifrah, Y Lamy, B Audhuy, P Colombat, JL Harousseau
Journal: Blood
Blood (1996) 88 (4): 1198–1205.
https://doi.org/10.1182/blood.V88.4.1198.bloodjournal8841198
Published: 1996
Journal Articles

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

P Fenaux, S Castaigne, H Dombret, E Archimbaud, M Duarte, P Morel, T Lamy, H Tilly, A Guerci, F Maloisel
Journal: Blood
Blood (1992) 80 (9): 2176–2181.
https://doi.org/10.1182/blood.V80.9.2176.2176
Published: 1992